Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Phenylephrine, Acetaminophen, and Dimethindene vs Phenylephrine in Healthy Volunteers
NCT01026961Phase 2Withdrawn
- Sponsor
- Novartis
- Start
- Sep 2010
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of phenylephrine, acetaminophen and dimethindene maleate in common cold (2 arms), sponsored by Novartis. Primary endpoint: Vital signs at 15 days. Planned start Sep 2010; status: withdrawn.
02
Drugs
phenylephrineacetaminophendimethindene maleate
03
Conditions
common cold
Beyond the preview
Go deeper on NCT01026961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01026961.